前年8.48分,去年11.53,今年或超20分,最快1周接受!
2022/6/24 15:51:26 阅读:171 发布者:
今天,我们来看看这本SCI期刊:Cellular & Molecular Immunology。从现有的记录来看,Cellular & Molecular Immunology的2021年影响因子(JCR2020)是11.530,2020年是8.484,比2020年增长3.046,增长比例35.90%。
关于此刊的具体情况,大家可以看看:
https://www.nature.com/cmi/
Cellular & Molecular Immunology 的收稿范围,期刊是如此介绍的(截取部分内容),详情请阅读:
https://www.nature.com/cmi/aims
Cellular & Molecular Immunologyis a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications,Cellular & Molecular Immunologyprovides the latest information and advancements in our understanding of the immunological response of the host, bothin vitroandin vivo.
The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to:
clinical immunology
comparative immunology
immunobiology
immunogenetics
immunological techniques
immunopathology
immunopharmacology
infection immunology
neuroimmunology
transplantation immunology
tumor immunology
veterinary immunology
对于 Cellular & Molecular Immunology 的接受时间,我们看了几篇新近发表的:最快7天就可以接受!Received: 24 March 2022, Accepted: 2 April 2022
Received: 12 September 2021, Accepted: 8 December 2021
Received: 30 August 2021, Accepted: 15 November 2021
Received: 1 October 2021, Accepted: 20 March 2022
对于 Cellular & Molecular Immunology 的发文量,2018年发文70多篇,2019年发文70多篇,2020年发文170多篇,2021年发文100篇,截止2022年5月27日已发文30多篇。影响因子
即时影响因子计算发现,2022年5月27日,22.064分。按照常规期刊计算方法,以及往年经验,在2022年6月份公布的IF中,它或许在22分左右!期待6月份新IF的公布!
想必大家对如何投稿,也很感兴趣,这里我们简单介绍一下投稿界面https://mts-cmi.nature.com/cgi-bin/main.plex
如果还没有注册过账户,只需点击“Register for an account”注册账户即可!
有11+分以上发表要求的,来看看这个潜力股的SCI期刊吧!
今天,我们来看看这本SCI期刊:Cellular & Molecular Immunology。从现有的记录来看,Cellular & Molecular Immunology的2021年影响因子(JCR2020)是11.530,2020年是8.484,比2020年增长3.046,增长比例35.90%。
关于此刊的具体情况,大家可以看看:
https://www.nature.com/cmi/
Cellular & Molecular Immunology 的收稿范围,期刊是如此介绍的(截取部分内容),详情请阅读:
https://www.nature.com/cmi/aims
Cellular & Molecular Immunologyis a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications,Cellular & Molecular Immunologyprovides the latest information and advancements in our understanding of the immunological response of the host, bothin vitroandin vivo.
The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to:
clinical immunology
comparative immunology
immunobiology
immunogenetics
immunological techniques
immunopathology
immunopharmacology
infection immunology
neuroimmunology
transplantation immunology
tumor immunology
veterinary immunology
对于 Cellular & Molecular Immunology 的接受时间,我们看了几篇新近发表的:最快7天就可以接受!Received: 24 March 2022, Accepted: 2 April 2022
Received: 12 September 2021, Accepted: 8 December 2021
Received: 30 August 2021, Accepted: 15 November 2021
Received: 1 October 2021, Accepted: 20 March 2022
对于 Cellular & Molecular Immunology 的发文量,2018年发文70多篇,2019年发文70多篇,2020年发文170多篇,2021年发文100篇,截止2022年5月27日已发文30多篇。影响因子
即时影响因子计算发现,2022年5月27日,22.064分。按照常规期刊计算方法,以及往年经验,在2022年6月份公布的IF中,它或许在22分左右!期待6月份新IF的公布!
想必大家对如何投稿,也很感兴趣,这里我们简单介绍一下投稿界面https://mts-cmi.nature.com/cgi-bin/main.plex
如果还没有注册过账户,只需点击“Register for an account”注册账户即可!
有11+分以上发表要求的,来看看这个潜力股的SCI期刊吧!
如有侵权,请联系本站删除!